Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Equity Average (2018 - 2026)

Health Catalyst filings provide 9 years of Equity Average readings, the most recent being $192.0 million for Q1 2026.

  • On a quarterly basis, Equity Average fell 48.26% to $192.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $192.0 million, a 48.26% decrease, with the full-year FY2025 number at $305.5 million, down 16.55% from a year prior.
  • Equity Average hit $192.0 million in Q1 2026 for Health Catalyst, down from $288.9 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $501.5 million in Q1 2022 to a low of $192.0 million in Q1 2026.
  • Median Equity Average over the past 5 years was $371.0 million (2025), compared with a mean of $378.0 million.
  • Biggest five-year swings in Equity Average: surged 84.06% in 2022 and later plummeted 48.26% in 2026.
  • Health Catalyst's Equity Average stood at $432.5 million in 2022, then decreased by 13.37% to $374.7 million in 2023, then dropped by 3.88% to $360.1 million in 2024, then fell by 19.79% to $288.9 million in 2025, then crashed by 33.54% to $192.0 million in 2026.
  • The last three reported values for Equity Average were $192.0 million (Q1 2026), $288.9 million (Q4 2025), and $339.7 million (Q3 2025) per Business Quant data.